US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biogen

169.91

-2.1900-1.27%

Post-market: 169.910.00000.00%19:59 EST

Volume:2.76M

Turnover:469.96M

Market Cap:24.93B

PE:15.48

High:173.00

Open:171.59

Low:168.56

Close:172.10

52wk High:185.17

52wk Low:110.04

Shares:146.70M

Float Shares:146.23M

Volume Ratio:1.15

T/O Rate:1.89%

Dividend:- -

Dividend Rate:- -

EPS(TTM):10.97

EPS(LYR):11.21

ROE:9.31%

ROA:5.75%

PB:1.37

PE(LYR):15.16

Loading ...

Overview Company News Filings

Biogen Shares New Leqembi Data on Slower Alzheimer's Progression, Injection Option

MT Newswires Live

Should New LEQEMBI Data and Subcutaneous Option Shift the Risk Profile for Biogen (BIIB) Investors?

Simply Wall St.

Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment

Eisai Presents New Data on the Continued and Expanding Benefit of Leqembi® (Lecanemab-Irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (Ctad) Conference 2025

THOMSON REUTERS

Biogen and Eisai Present New LEQEMBI Biomarker Data at Clinical Trials on Alzheimer's Disease 2025 Conference

MT Newswires Live

Biogen Inc. Stock Outperforms Competitors On Strong Trading Day

Biogen Announces New Data Confirming LEQEMBI Reduces Neurotoxic Amyloid Protofibrils in Alzheimer's Disease

New Data Presented at the Clinical Trials on Alzheimer's Disease (Ctad) Conference 2025 Confirms Pharmacological Effect of Leqembi® (Lecanemab-Irmb) on Neurotoxic aΒ Protofibrils in Csf

THOMSON REUTERS

Biogen Inc. Stock Underperforms Monday When Compared To Competitors

Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements

Tiger Newspress

Stoke Therapeutics Reports Zorevunersen Shows Disease-Modifying Effects in Dravet Syndrome Study

Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting

A Look at Biogen's Valuation as It Expands Immunology Pipeline With Dayra Therapeutics Collaboration

Simply Wall St.

Sector Update: Health Care Stocks Mixed Premarket Friday

MT Newswires Live

U.S. RESEARCH ROUNDUP-Biogen, Deere & Co, Sherwin-Williams

Jefferies Adjusts Price Target on Biogen to $210 From $190, Maintains Buy Rating

MT Newswires Live

Eisai and Biogen Submit Subcutaneous LEQEMBI for Regulatory Review in Japan

FDA Decision Opens Bigger Market for Novartis's Blockbuster Gene Therapy -- Barrons.com

BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-11-25

Biogen, Eisai Submit Supplemental Biologics License Application to FDA for Weekly Lecanemab Injections

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BIIB/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIIB\",,,,,undefined,":{"symbol":"BIIB","market":"US","secType":"STK","nameCN":"Biogen","latestPrice":169.91,"timestamp":1766091600000,"preClose":172.1,"halted":0,"volume":2761008,"hourTrading":{"tag":"盘后","latestPrice":169.91,"preClose":169.91,"latestTime":"19:59 EST","volume":79647,"amount":13532792.3872,"timestamp":1766105961332},"delay":0,"floatShares":146226846,"shares":146702272,"eps":10.974839,"marketStatus":"Closed","change":-2.19,"latestTime":"12-18 16:00:00 EST","open":171.59,"high":173,"low":168.56,"amount":469961332.18944,"amplitude":0.025799,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":10.974839,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1766134800000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":685080000000,"exchange":"NASDAQ","adjPreClose":172.1,"preHourTrading":{"tag":"盘前","latestPrice":171.73,"preClose":172.1,"latestTime":"09:29 EST","volume":134,"amount":22968.712199999998,"timestamp":1766068170044},"postHourTrading":{"tag":"盘后","latestPrice":169.91,"preClose":169.91,"latestTime":"19:59 EST","volume":79647,"amount":13532792.3872,"timestamp":1766105961332},"volumeRatio":1.151677,"impliedVol":0.3354,"impliedVolPercentile":0.176},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIIB\",,,,,undefined,":{"symbol":"BIIB","floatShares":146226846,"roa":"5.75%","roe":"9.31%","lyrEps":11.210164,"volumeRatio":1.151677,"shares":146702272,"dividePrice":0,"high":173,"amplitude":0.025799,"preClose":172.1,"low":168.56,"week52Low":110.035,"pbRate":"1.37","psRate":"2.48","week52High":185.17,"institutionHeld":0.8451,"latestPrice":169.91,"eps":10.974839,"divideRate":0,"volume":2761008,"delay":0,"ttmEps":10.974839,"open":171.59,"prevYearClose":152.92,"prevWeekClose":174.1,"prevMonthClose":182.09,"prevQuarterClose":140.08,"fiveDayClose":172.5,"twentyDayClose":167.93,"sixtyDayClose":137.67,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIIB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-30","symbol":"BIIB","fiscalQuarterEnding":"2025/09","expectedEps":3.89,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":4.81},{"market":"US","date":"2025-07-31","symbol":"BIIB","fiscalQuarterEnding":"2025/06","expectedEps":3.93,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":5.47},{"market":"US","date":"2025-05-01","symbol":"BIIB","fiscalQuarterEnding":"2025/03","expectedEps":3.26,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746072000000,"reportTimeType":"pre","actualEps":3.02},{"market":"US","date":"2025-02-12","symbol":"BIIB","fiscalQuarterEnding":"2024/12","expectedEps":3.42,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":3.44},{"market":"US","date":"2024-10-30","symbol":"BIIB","fiscalQuarterEnding":"2024/09","expectedEps":3.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730260800000,"reportTimeType":"pre","actualEps":4.08}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIIB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIIB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1944,"buy":0.2222,"hold":0.5556,"sell":0.0278,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2222,"analysts":36,"updateTime":1765861200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BIIB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BIIB","date":"2025-12-17","current":15.541914,"percent":0.553834,"low":7.355882,"twenty":12.975038,"median":14.676206,"eighty":23.767576,"high":29.553699,"avg":17.514761,"sd":5.577589,"marketCap":25159439648},"quantilePoints":[{"date":"2020-12-18","current":7.557832,"twenty":9.090973,"median":16.745647,"eighty":20.967974,"marketCap":38411924243},{"date":"2020-12-24","current":7.535729,"twenty":9.011245,"median":16.712559,"eighty":20.923425,"marketCap":38299590677},{"date":"2020-12-31","current":7.413712,"twenty":8.881734,"median":16.62625,"eighty":20.871689,"marketCap":37679447841},{"date":"2021-01-08","current":7.646242,"twenty":8.771333,"median":16.5374,"eighty":20.774938,"marketCap":38861258506},{"date":"2021-01-15","current":8.351704,"twenty":8.712798,"median":16.502814,"eighty":20.651824,"marketCap":42446699716},{"date":"2021-01-22","current":8.157929,"twenty":8.604345,"median":16.461569,"eighty":20.586908,"marketCap":41461857495},{"date":"2021-01-29","current":8.556682,"twenty":8.514078,"median":16.392872,"eighty":20.49891,"marketCap":43488478128},{"date":"2021-02-05","current":10.094156,"twenty":8.500791,"median":16.345496,"eighty":20.411283,"marketCap":40382678930},{"date":"2021-02-12","current":10.586888,"twenty":8.500791,"median":16.278386,"eighty":20.374501,"marketCap":42353903289},{"date":"2021-02-19","current":10.599073,"twenty":8.500791,"median":16.233805,"eighty":20.245858,"marketCap":42402650723},{"date":"2021-02-26","current":10.390785,"twenty":8.500791,"median":16.187357,"eighty":20.203066,"marketCap":41569374275},{"date":"2021-03-05","current":10.308155,"twenty":8.497203,"median":16.154964,"eighty":20.174961,"marketCap":41238805739},{"date":"2021-03-12","current":10.133757,"twenty":8.497203,"median":16.125084,"eighty":20.070907,"marketCap":40541108091},{"date":"2021-03-19","current":10.16955,"twenty":8.497203,"median":16.113083,"eighty":19.981443,"marketCap":40684303678},{"date":"2021-03-26","current":10.533578,"twenty":8.500791,"median":16.049312,"eighty":19.941245,"marketCap":42140633266},{"date":"2021-04-01","current":10.612781,"twenty":8.500791,"median":15.98416,"eighty":19.889259,"marketCap":42457491587},{"date":"2021-04-09","current":10.09204,"twenty":8.497203,"median":15.949172,"eighty":19.764693,"marketCap":40374215282},{"date":"2021-04-16","current":10.172575,"twenty":8.497203,"median":15.921399,"eighty":19.722098,"marketCap":40696402032},{"date":"2021-04-23","current":13.128862,"twenty":8.497203,"median":15.875061,"eighty":19.696106,"marketCap":39540193992},{"date":"2021-04-30","current":13.363815,"twenty":8.497203,"median":15.807955,"eighty":19.696106,"marketCap":40247801317},{"date":"2021-05-07","current":13.699247,"twenty":8.497203,"median":15.723881,"eighty":19.696106,"marketCap":41258023690},{"date":"2021-05-14","current":14.007686,"twenty":8.497203,"median":15.670061,"eighty":19.696106,"marketCap":42186946497},{"date":"2021-05-21","current":14.156656,"twenty":8.497203,"median":15.60416,"eighty":19.696106,"marketCap":42635599652},{"date":"2021-05-28","current":13.371313,"twenty":8.497203,"median":15.573174,"eighty":19.696106,"marketCap":40270384530},{"date":"2021-06-04","current":14.304126,"twenty":8.497203,"median":15.557418,"eighty":19.696106,"marketCap":43079736165},{"date":"2021-06-11","current":19.828016,"twenty":8.497203,"median":15.557418,"eighty":19.745578,"marketCap":59716036040},{"date":"2021-06-18","current":19.418098,"twenty":8.497203,"median":15.557418,"eighty":19.755193,"marketCap":58481487090},{"date":"2021-06-25","current":17.393005,"twenty":8.497203,"median":15.567751,"eighty":19.755193,"marketCap":52382514167},{"date":"2021-07-02","current":17.432497,"twenty":8.497203,"median":15.570047,"eighty":19.755193,"marketCap":52501452420},{"date":"2021-07-09","current":17.904403,"twenty":8.497203,"median":15.570047,"eighty":19.755193,"marketCap":53922689260},{"date":"2021-07-16","current":16.227739,"twenty":8.497203,"median":15.570047,"eighty":19.755193,"marketCap":48873082945},{"date":"2021-07-23","current":25.283083,"twenty":8.497203,"median":15.570047,"eighty":19.764693,"marketCap":48495482352},{"date":"2021-07-30","current":25.386422,"twenty":8.497203,"median":15.570047,"eighty":19.810328,"marketCap":48693696831},{"date":"2021-08-06","current":26.417481,"twenty":8.497203,"median":15.570047,"eighty":19.852416,"marketCap":50671370620},{"date":"2021-08-13","current":26.592303,"twenty":8.497203,"median":15.570047,"eighty":19.944153,"marketCap":51006695866},{"date":"2021-08-20","current":26.552677,"twenty":8.497203,"median":15.570047,"eighty":19.994038,"marketCap":50930688810},{"date":"2021-08-27","current":26.665339,"twenty":8.497203,"median":15.570047,"eighty":20.098571,"marketCap":51146787303},{"date":"2021-09-03","current":25.920211,"twenty":8.497203,"median":15.570047,"eighty":20.189206,"marketCap":49717556584},{"date":"2021-09-10","current":23.294779,"twenty":8.497203,"median":15.570047,"eighty":20.204127,"marketCap":44681716545},{"date":"2021-09-17","current":23.324305,"twenty":8.497203,"median":15.570047,"eighty":20.247225,"marketCap":44738349254},{"date":"2021-09-24","current":22.665422,"twenty":8.497203,"median":15.570047,"eighty":20.354794,"marketCap":43474545657},{"date":"2021-10-01","current":22.061705,"twenty":8.497203,"median":15.570047,"eighty":20.406509,"marketCap":42316555805},{"date":"2021-10-08","current":22.208555,"twenty":8.497203,"median":15.570047,"eighty":20.49184,"marketCap":42598229012},{"date":"2021-10-15","current":21.848034,"twenty":8.497203,"median":15.570047,"eighty":20.56935,"marketCap":41906713837},{"date":"2021-10-22","current":25.163145,"twenty":8.497203,"median":15.570047,"eighty":20.652077,"marketCap":38897190137},{"date":"2021-10-29","current":25.341796,"twenty":8.497203,"median":15.570047,"eighty":20.775909,"marketCap":39173348436},{"date":"2021-11-05","current":26.48212,"twenty":8.497203,"median":15.570047,"eighty":20.846596,"marketCap":40936060980},{"date":"2021-11-12","current":25.698147,"twenty":8.497203,"median":15.570047,"eighty":20.923635,"marketCap":39724196106},{"date":"2021-11-19","current":24.43999,"twenty":8.497203,"median":15.570047,"eighty":20.97455,"marketCap":37779336599},{"date":"2021-11-26","current":23.082054,"twenty":8.497203,"median":15.570047,"eighty":21.028174,"marketCap":35680239744},{"date":"2021-12-03","current":21.278442,"twenty":8.497203,"median":15.570047,"eighty":21.079902,"marketCap":32892216071},{"date":"2021-12-10","current":22.105177,"twenty":8.497203,"median":15.570047,"eighty":21.201871,"marketCap":34170182665},{"date":"2021-12-17","current":22.562257,"twenty":8.497203,"median":15.570047,"eighty":21.294992,"marketCap":34876736610},{"date":"2021-12-23","current":22.370302,"twenty":8.497203,"median":15.570047,"eighty":21.362909,"marketCap":34580013331},{"date":"2021-12-31","current":22.798874,"twenty":8.497203,"median":15.570047,"eighty":21.502724,"marketCap":35242499463},{"date":"2022-01-07","current":22.103276,"twenty":8.500791,"median":15.57263,"eighty":21.634937,"marketCap":34167244811},{"date":"2022-01-14","current":22.739957,"twenty":8.500791,"median":15.57263,"eighty":21.738204,"marketCap":35151425981},{"date":"2022-01-21","current":20.955351,"twenty":8.500791,"median":15.57263,"eighty":21.764755,"marketCap":32392780850},{"date":"2022-01-28","current":21.401027,"twenty":8.500791,"median":15.57263,"eighty":21.764755,"marketCap":33081707669},{"date":"2022-02-04","current":20.921964,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":32556667533},{"date":"2022-02-11","current":20.266529,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31536745749},{"date":"2022-02-18","current":19.813202,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30831324343},{"date":"2022-02-25","current":19.585595,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30477144012},{"date":"2022-03-04","current":19.781092,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30781356993},{"date":"2022-03-11","current":18.668553,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":29050135292},{"date":"2022-03-18","current":19.697982,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30652029736},{"date":"2022-03-25","current":19.924645,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31004740439},{"date":"2022-04-01","current":19.894423,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30957712345},{"date":"2022-04-08","current":20.28164,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31560259796},{"date":"2022-04-14","current":20.073865,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":31236941652},{"date":"2022-04-22","current":19.832091,"twenty":8.500791,"median":15.57263,"eighty":21.790769,"marketCap":30860716902},{"date":"2022-04-29","current":19.616341,"twenty":8.500791,"median":15.575787,"eighty":21.790769,"marketCap":30524988504},{"date":"2022-05-06","current":19.558925,"twenty":8.500791,"median":15.608505,"eighty":21.790769,"marketCap":28354574236},{"date":"2022-05-13","current":20.114548,"twenty":8.500791,"median":15.692187,"eighty":21.790769,"marketCap":29160060308},{"date":"2022-05-20","current":20.1691,"twenty":8.500791,"median":15.775496,"eighty":21.790769,"marketCap":29239144395},{"date":"2022-05-27","current":20.830796,"twenty":8.500791,"median":15.860843,"eighty":21.790769,"marketCap":30198405080},{"date":"2022-06-03","current":20.267092,"twenty":8.500791,"median":15.945572,"eighty":21.790769,"marketCap":29381202848},{"date":"2022-06-10","current":19.951902,"twenty":8.500791,"median":15.991048,"eighty":21.790769,"marketCap":28924272567},{"date":"2022-06-17","current":20.380237,"twenty":8.500791,"median":16.09785,"eighty":21.790769,"marketCap":29545229102},{"date":"2022-06-24","current":21.409654,"twenty":8.497203,"median":16.123616,"eighty":21.791778,"marketCap":31037575115},{"date":"2022-07-01","current":21.278325,"twenty":8.497203,"median":16.204744,"eighty":21.791778,"marketCap":30847187498},{"date":"2022-07-08","current":22.103677,"twenty":8.497203,"median":16.239917,"eighty":21.812733,"marketCap":32043700444},{"date":"2022-07-15","current":21.922847,"twenty":8.497203,"median":16.404704,"eighty":21.82315,"marketCap":31781551341},{"date":"2022-07-22","current":14.53456,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":29929565943},{"date":"2022-07-29","current":15.155406,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":31208011887},{"date":"2022-08-05","current":15.376684,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":31663666855},{"date":"2022-08-12","current":15.573297,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":32068532256},{"date":"2022-08-19","current":15.087049,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":31067252232},{"date":"2022-08-26","current":13.994755,"twenty":8.497203,"median":16.750724,"eighty":21.836233,"marketCap":28818000003},{"date":"2022-09-02","current":13.814351,"twenty":8.497203,"median":16.227739,"eighty":21.836233,"marketCap":28446510603},{"date":"2022-09-09","current":14.928491,"twenty":8.497203,"median":15.671251,"eighty":21.836233,"marketCap":30740747876},{"date":"2022-09-16","current":14.676206,"twenty":8.497203,"median":15.376684,"eighty":21.836233,"marketCap":30221243168},{"date":"2022-09-23","current":13.937674,"twenty":8.497203,"median":15.31326,"eighty":21.836233,"marketCap":28700458435},{"date":"2022-09-30","current":18.815649,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":38745183549},{"date":"2022-10-07","current":18.173661,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":37423203690},{"date":"2022-10-14","current":18.648633,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":38401265627},{"date":"2022-10-21","current":18.858988,"twenty":8.497203,"median":15.210215,"eighty":21.836233,"marketCap":38834428072},{"date":"2022-10-28","current":14.290557,"twenty":8.497203,"median":15.094801,"eighty":21.836233,"marketCap":40938159143},{"date":"2022-11-04","current":14.166396,"twenty":8.497203,"median":15.004599,"eighty":21.836233,"marketCap":40582475675},{"date":"2022-11-11","current":14.549938,"twenty":8.497203,"median":14.858725,"eighty":21.836233,"marketCap":41681206387},{"date":"2022-11-18","current":15.225533,"twenty":8.497203,"median":14.858725,"eighty":21.836233,"marketCap":43616585257},{"date":"2022-11-25","current":15.339138,"twenty":8.497203,"median":14.858725,"eighty":21.836233,"marketCap":43942028430},{"date":"2022-12-02","current":15.024966,"twenty":8.497203,"median":14.794781,"eighty":21.836233,"marketCap":43042019655},{"date":"2022-12-09","current":14.344846,"twenty":8.497203,"median":14.738925,"eighty":21.836233,"marketCap":41093680659},{"date":"2022-12-16","current":14.325242,"twenty":8.497203,"median":14.656474,"eighty":21.836233,"marketCap":41037520111},{"date":"2022-12-23","current":14.032685,"twenty":8.497203,"median":14.636742,"eighty":21.836233,"marketCap":40199431940},{"date":"2022-12-30","current":13.920085,"twenty":8.497203,"median":14.607243,"eighty":21.836233,"marketCap":39876868795},{"date":"2023-01-06","current":14.037209,"twenty":8.497203,"median":14.549938,"eighty":21.836233,"marketCap":40212392067},{"date":"2023-01-13","current":14.47906,"twenty":8.497203,"median":14.529831,"eighty":21.836233,"marketCap":41478164408},{"date":"2023-01-20","current":14.364953,"twenty":8.497203,"median":14.481071,"eighty":21.836233,"marketCap":41151281221},{"date":"2023-01-27","current":14.581606,"twenty":8.497203,"median":14.481071,"eighty":21.812733,"marketCap":41771927272},{"date":"2023-02-03","current":14.257381,"twenty":8.497203,"median":14.452921,"eighty":21.766456,"marketCap":40843118216},{"date":"2023-02-10","current":14.391595,"twenty":8.497203,"median":14.434492,"eighty":21.713568,"marketCap":41227601965},{"date":"2023-02-17","current":13.20093,"twenty":8.497203,"median":14.416076,"eighty":21.633442,"marketCap":40221914133},{"date":"2023-02-24","current":12.804494,"twenty":8.497203,"median":14.383753,"eighty":21.580551,"marketCap":39014014132},{"date":"2023-03-03","current":12.81635,"twenty":8.497203,"median":14.348868,"eighty":21.467685,"marketCap":39050135544},{"date":"2023-03-10","current":12.166214,"twenty":8.497203,"median":14.307145,"eighty":21.413931,"marketCap":37069237337},{"date":"2023-03-17","current":12.47919,"twenty":8.497203,"median":14.275339,"eighty":21.363363,"marketCap":38022842601},{"date":"2023-03-24","current":12.804969,"twenty":8.497203,"median":14.24783,"eighty":21.306875,"marketCap":39015458989},{"date":"2023-03-31","current":13.184333,"twenty":8.500791,"median":14.205292,"eighty":21.276954,"marketCap":40171344157},{"date":"2023-04-06","current":13.466959,"twenty":8.500791,"median":14.152478,"eighty":21.176842,"marketCap":41032478607},{"date":"2023-04-14","current":13.737731,"twenty":8.497203,"median":14.096524,"eighty":21.070262,"marketCap":41857491646},{"date":"2023-04-21","current":13.76476,"twenty":8.497203,"median":14.07932,"eighty":21.005659,"marketCap":41939848464},{"date":"2023-04-28","current":13.578317,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":42513709824},{"date":"2023-05-05","current":14.495964,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":45386864333},{"date":"2023-05-12","current":14.356816,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":44951189806},{"date":"2023-05-19","current":14.120586,"twenty":8.497203,"median":14.037209,"eighty":21.003669,"marketCap":44211556305},{"date":"2023-05-26","current":13.735963,"twenty":8.497203,"median":14.01426,"eighty":21.003669,"marketCap":43007299803},{"date":"2023-06-02","current":13.980051,"twenty":8.497203,"median":13.992973,"eighty":20.997841,"marketCap":43771539506},{"date":"2023-06-09","current":14.279151,"twenty":8.497203,"median":13.96784,"eighty":20.929644,"marketCap":44708022627},{"date":"2023-06-16","current":13.768323,"twenty":8.497203,"median":13.941165,"eighty":20.892332,"marketCap":43108619461},{"date":"2023-06-23","current":13.588955,"twenty":8.493614,"median":13.935626,"eighty":20.867377,"marketCap":42547019073},{"date":"2023-06-30","current":13.042531,"twenty":8.490026,"median":13.890459,"eighty":20.867651,"marketCap":40836164283},{"date":"2023-07-07","current":13.174745,"twenty":8.490026,"median":13.868177,"eighty":20.815502,"marketCap":41250127456},{"date":"2023-07-14","current":12.850219,"twenty":8.490026,"median":13.817874,"eighty":20.73251,"marketCap":40234036032},{"date":"2023-07-21","current":12.699051,"twenty":8.490026,"median":13.806693,"eighty":20.629889,"marketCap":39760728489},{"date":"2023-07-28","current":14.282866,"twenty":8.490026,"median":13.794619,"eighty":20.526137,"marketCap":38058124204},{"date":"2023-08-04","current":14.552446,"twenty":8.490026,"median":13.794619,"eighty":20.460449,"marketCap":38776447946},{"date":"2023-08-11","current":14.623646,"twenty":8.490026,"median":13.794619,"eighty":20.395995,"marketCap":38966166515},{"date":"2023-08-18","current":14.212753,"twenty":8.490026,"median":13.794619,"eighty":20.321644,"marketCap":37871302102},{"date":"2023-08-25","current":14.263299,"twenty":8.490026,"median":13.794619,"eighty":20.266979,"marketCap":38005987804},{"date":"2023-09-01","current":14.531249,"twenty":8.486438,"median":13.786176,"eighty":20.242472,"marketCap":38719966845},{"date":"2023-09-08","current":14.204057,"twenty":8.486438,"median":13.786176,"eighty":20.208919,"marketCap":37848130368},{"date":"2023-09-15","current":13.931216,"twenty":8.486438,"median":13.786176,"eighty":20.198211,"marketCap":37121117227},{"date":"2023-09-22","current":14.073071,"twenty":8.486438,"median":13.776523,"eighty":20.143845,"marketCap":37499106131},{"date":"2023-09-29","current":14.013285,"twenty":8.486438,"median":13.776523,"eighty":20.072921,"marketCap":37339800463},{"date":"2023-10-06","current":14.118726,"twenty":8.486438,"median":13.768434,"eighty":19.9917,"marketCap":37620757732},{"date":"2023-10-13","current":14.185034,"twenty":8.486438,"median":13.768434,"eighty":19.951902,"marketCap":37797442201},{"date":"2023-10-20","current":13.98448,"twenty":8.486438,"median":13.768434,"eighty":19.927657,"marketCap":37263044095},{"date":"2023-10-27","current":13.102908,"twenty":8.47807,"median":13.76476,"eighty":19.922756,"marketCap":34914009601},{"date":"2023-11-03","current":13.145302,"twenty":8.47807,"median":13.737731,"eighty":19.916955,"marketCap":35026971803},{"date":"2023-11-10","current":22.267999,"twenty":8.47807,"median":13.71992,"eighty":19.89329,"marketCap":32551360860},{"date":"2023-11-17","current":22.744781,"twenty":8.47807,"median":13.71992,"eighty":19.905271,"marketCap":33248320779},{"date":"2023-11-24","current":22.991597,"twenty":8.47807,"median":13.71992,"eighty":19.905271,"marketCap":33609117078},{"date":"2023-12-01","current":23.20273,"twenty":8.47807,"median":13.71992,"eighty":19.905271,"marketCap":33917750056},{"date":"2023-12-08","current":23.70231,"twenty":8.48086,"median":13.727942,"eighty":19.915471,"marketCap":34648036541},{"date":"2023-12-14","current":25.331893,"twenty":8.48086,"median":13.727942,"eighty":19.915471,"marketCap":37030161502},{"date":"2023-12-22","current":25.163384,"twenty":8.475281,"median":13.713268,"eighty":19.929934,"marketCap":36783834712},{"date":"2023-12-29","current":25.829491,"twenty":8.470794,"median":13.704438,"eighty":19.950281,"marketCap":37757550024},{"date":"2024-01-05","current":25.799754,"twenty":8.469944,"median":13.703558,"eighty":19.987922,"marketCap":37714080591},{"date":"2024-01-12","current":24.504216,"twenty":8.469944,"median":13.703558,"eighty":19.987922,"marketCap":35820262267},{"date":"2024-01-19","current":24.480426,"twenty":8.469095,"median":13.702678,"eighty":19.980718,"marketCap":35785486720},{"date":"2024-01-26","current":24.405092,"twenty":8.469944,"median":13.703558,"eighty":19.987922,"marketCap":35675364155},{"date":"2024-02-02","current":24.565672,"twenty":8.469944,"median":13.703558,"eighty":20.065327,"marketCap":35910099096},{"date":"2024-02-09","current":23.819275,"twenty":8.469944,"median":13.703558,"eighty":20.158998,"marketCap":34819016313},{"date":"2024-02-16","current":27.961704,"twenty":8.469944,"median":13.703558,"eighty":20.245941,"marketCap":32466334233},{"date":"2024-02-23","current":27.852786,"twenty":8.469944,"median":13.703558,"eighty":20.275821,"marketCap":32339870339},{"date":"2024-03-01","current":27.165481,"twenty":8.470794,"median":13.704438,"eighty":20.331364,"marketCap":31541839558},{"date":"2024-03-08","current":27.462186,"twenty":8.470794,"median":13.704438,"eighty":20.459236,"marketCap":31886344649},{"date":"2024-03-15","current":27.494736,"twenty":8.470794,"median":13.71992,"eighty":20.628123,"marketCap":31924138456},{"date":"2024-03-22","current":27.636204,"twenty":8.470794,"median":13.735963,"eighty":20.786154,"marketCap":32088396158},{"date":"2024-03-28","current":27.084106,"twenty":8.470794,"median":13.752143,"eighty":20.831794,"marketCap":31447355039},{"date":"2024-04-05","current":25.701982,"twenty":8.469944,"median":13.77193,"eighty":20.907169,"marketCap":29842571829},{"date":"2024-04-12","current":25.499171,"twenty":8.469944,"median":13.808789,"eighty":21.038884,"marketCap":29607087336},{"date":"2024-04-19","current":23.85164,"twenty":8.469944,"median":13.85217,"eighty":21.289275,"marketCap":27694139234},{"date":"2024-04-26","current":25.267913,"twenty":8.470794,"median":13.868177,"eighty":21.404478,"marketCap":29477547361},{"date":"2024-05-03","current":26.647002,"twenty":8.470794,"median":13.908932,"eighty":21.47563,"marketCap":31086393051},{"date":"2024-05-10","current":27.800196,"twenty":8.470794,"median":13.937674,"eighty":21.648875,"marketCap":32431708361},{"date":"2024-05-17","current":28.71002,"twenty":8.470794,"median":13.950238,"eighty":21.782935,"marketCap":33493109725},{"date":"2024-05-24","current":27.214863,"twenty":8.470794,"median":13.980051,"eighty":21.877959,"marketCap":31748858923},{"date":"2024-05-31","current":27.46572,"twenty":8.470794,"median":13.994755,"eighty":22.000262,"marketCap":32041508682},{"date":"2024-06-07","current":28.953389,"twenty":8.470794,"median":14.01426,"eighty":22.073132,"marketCap":33777023671},{"date":"2024-06-14","current":29.184277,"twenty":8.469944,"median":14.041825,"eighty":22.114991,"marketCap":34046377926},{"date":"2024-06-21","current":28.153392,"twenty":8.469095,"median":14.072528,"eighty":22.189441,"marketCap":32843747574},{"date":"2024-06-28","current":28.545278,"twenty":8.464282,"median":14.07812,"eighty":22.231423,"marketCap":33300921824},{"date":"2024-07-05","current":28.032332,"twenty":8.464282,"median":14.08367,"eighty":22.274713,"marketCap":32702518585},{"date":"2024-07-12","current":29.553699,"twenty":8.464282,"median":14.11215,"eighty":22.314226,"marketCap":34477344736},{"date":"2024-07-15","current":28.712516,"twenty":8.464282,"median":14.119656,"eighty":22.340794,"marketCap":33496021663},{"date":"2024-08-02","current":26.48965,"twenty":8.513869,"median":14.166396,"eighty":22.380755,"marketCap":30690907969},{"date":"2024-08-09","current":25.656112,"twenty":8.592131,"median":14.204057,"eighty":22.479723,"marketCap":29725171282},{"date":"2024-08-16","current":25.34935,"twenty":8.71649,"median":14.24783,"eighty":22.562257,"marketCap":29369756876},{"date":"2024-08-23","current":25.56182,"twenty":8.771928,"median":14.263299,"eighty":22.739957,"marketCap":29615925051},{"date":"2024-08-30","current":25.750404,"twenty":8.883073,"median":14.292141,"eighty":22.781193,"marketCap":29834417514},{"date":"2024-09-06","current":25.370723,"twenty":9.022005,"median":14.304126,"eighty":22.950917,"marketCap":29394519355},{"date":"2024-09-13","current":24.879149,"twenty":9.165962,"median":14.325242,"eighty":22.991597,"marketCap":28824982335},{"date":"2024-09-20","current":25.325463,"twenty":9.324413,"median":14.348868,"eighty":23.181914,"marketCap":29342081164},{"date":"2024-09-27","current":24.339801,"twenty":9.391209,"median":14.369659,"eighty":23.258238,"marketCap":28200093891},{"date":"2024-10-04","current":23.230932,"twenty":9.429088,"median":14.383753,"eighty":23.324305,"marketCap":26915358208},{"date":"2024-10-11","current":23.709934,"twenty":9.504668,"median":14.406786,"eighty":23.460277,"marketCap":27470329064},{"date":"2024-10-18","current":23.830627,"twenty":9.553828,"median":14.419745,"eighty":23.728792,"marketCap":27610164241},{"date":"2024-10-25","current":23.115268,"twenty":9.604326,"median":14.473094,"eighty":23.76148,"marketCap":26781349498},{"date":"2024-10-31","current":16.34561,"twenty":9.604326,"median":14.485595,"eighty":23.76148,"marketCap":26401430021},{"date":"2024-11-08","current":15.690631,"twenty":9.628672,"median":14.521195,"eighty":23.763004,"marketCap":25343507612},{"date":"2024-11-15","current":14.875967,"twenty":9.644632,"median":14.532646,"eighty":23.763004,"marketCap":24027661972},{"date":"2024-11-22","current":14.255271,"twenty":9.699532,"median":14.532646,"eighty":23.763004,"marketCap":23025112913},{"date":"2024-11-29","current":14.49164,"twenty":9.699532,"median":14.532646,"eighty":23.763004,"marketCap":23406897584},{"date":"2024-12-06","current":14.368042,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":23207262088},{"date":"2024-12-13","current":14.013488,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":22634585082},{"date":"2024-12-20","current":13.29716,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":21477573522},{"date":"2024-12-27","current":13.523606,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":21843329066},{"date":"2025-01-03","current":13.532628,"twenty":9.707445,"median":14.533753,"eighty":23.763004,"marketCap":21857901000},{"date":"2025-01-10","current":13.600291,"twenty":9.764574,"median":14.53456,"eighty":23.764528,"marketCap":21967190505},{"date":"2025-01-17","current":12.74142,"twenty":9.816223,"median":14.53456,"eighty":23.764528,"marketCap":20579942388},{"date":"2025-01-24","current":12.961551,"twenty":9.886141,"median":14.53456,"eighty":23.764528,"marketCap":20935497577},{"date":"2025-01-31","current":13.192508,"twenty":9.95619,"median":14.53456,"eighty":23.764528,"marketCap":21308539088},{"date":"2025-02-07","current":12.844268,"twenty":9.977934,"median":14.53456,"eighty":23.764528,"marketCap":20746062435},{"date":"2025-02-14","current":12.416132,"twenty":10.002015,"median":14.53456,"eighty":23.764528,"marketCap":20265610027},{"date":"2025-02-21","current":12.293271,"twenty":10.031403,"median":14.53456,"eighty":23.764528,"marketCap":20065076363},{"date":"2025-02-28","current":12.544373,"twenty":10.117917,"median":14.53456,"eighty":23.764528,"marketCap":20474926187},{"date":"2025-03-07","current":13.216073,"twenty":10.153098,"median":14.534807,"eighty":23.766052,"marketCap":21571274465},{"date":"2025-03-14","current":12.553341,"twenty":10.179175,"median":14.534807,"eighty":23.766052,"marketCap":20489563681},{"date":"2025-03-21","current":12.678893,"twenty":10.263071,"median":14.534807,"eighty":23.766052,"marketCap":20694488593},{"date":"2025-03-28","current":12.584729,"twenty":10.356971,"median":14.534807,"eighty":23.766052,"marketCap":20540794909},{"date":"2025-04-04","current":11.722012,"twenty":10.485219,"median":14.534807,"eighty":23.766052,"marketCap":19132668015},{"date":"2025-04-11","current":10.167866,"twenty":10.511569,"median":14.53456,"eighty":23.764528,"marketCap":16595990357},{"date":"2025-04-17","current":10.339154,"twenty":10.525201,"median":14.53456,"eighty":23.764528,"marketCap":16875566486},{"date":"2025-04-25","current":10.717601,"twenty":10.591105,"median":14.534807,"eighty":23.766052,"marketCap":17493268720},{"date":"2025-05-02","current":11.978375,"twenty":10.630526,"median":14.534807,"eighty":23.766052,"marketCap":17719610723},{"date":"2025-05-09","current":11.726783,"twenty":10.67025,"median":14.534807,"eighty":23.766052,"marketCap":17347430030},{"date":"2025-05-16","current":12.25275,"twenty":10.766755,"median":14.534807,"eighty":23.766052,"marketCap":18125492818},{"date":"2025-05-23","current":12.510285,"twenty":10.926554,"median":14.534807,"eighty":23.766052,"marketCap":18506465181},{"date":"2025-05-30","current":13.149172,"twenty":11.711799,"median":14.534807,"eighty":23.766052,"marketCap":19451569698},{"date":"2025-06-06","current":12.912437,"twenty":11.91657,"median":14.534807,"eighty":23.766052,"marketCap":19101368179},{"date":"2025-06-13","current":13.105589,"twenty":12.213922,"median":14.534807,"eighty":23.766052,"marketCap":19387097451},{"date":"2025-06-20","current":12.534058,"twenty":12.262814,"median":14.535054,"eighty":23.767576,"marketCap":18541631861},{"date":"2025-06-27","current":12.571698,"twenty":12.329218,"median":14.535054,"eighty":23.767576,"marketCap":18597312437},{"date":"2025-07-03","current":13.161058,"twenty":12.420897,"median":14.535054,"eighty":23.767576,"marketCap":19469153037},{"date":"2025-07-11","current":13.404726,"twenty":12.46391,"median":14.535054,"eighty":23.767576,"marketCap":19829611504},{"date":"2025-07-18","current":12.74702,"twenty":12.505988,"median":14.535054,"eighty":23.767576,"marketCap":18856666700},{"date":"2025-07-25","current":13.133323,"twenty":12.534454,"median":14.535054,"eighty":23.767576,"marketCap":19428125244},{"date":"2025-08-01","current":12.261789,"twenty":12.554823,"median":14.535054,"eighty":23.767576,"marketCap":18766668544},{"date":"2025-08-08","current":12.237841,"twenty":12.571793,"median":14.535054,"eighty":23.767576,"marketCap":18730014894},{"date":"2025-08-15","current":12.926608,"twenty":12.574688,"median":14.535054,"eighty":23.767576,"marketCap":19784173854},{"date":"2025-08-22","current":13.327032,"twenty":12.599257,"median":14.535054,"eighty":23.767576,"marketCap":20397022873},{"date":"2025-08-29","current":12.707237,"twenty":12.629742,"median":14.535054,"eighty":23.767576,"marketCap":19448426424},{"date":"2025-09-05","current":13.405584,"twenty":12.664129,"median":14.542496,"eighty":23.7691,"marketCap":20517246844},{"date":"2025-09-12","current":14.258162,"twenty":12.679129,"median":14.535054,"eighty":23.767576,"marketCap":21822116766},{"date":"2025-09-19","current":13.776312,"twenty":12.704997,"median":14.535054,"eighty":23.767576,"marketCap":21084645338},{"date":"2025-09-26","current":12.996539,"twenty":12.719227,"median":14.535054,"eighty":23.767576,"marketCap":19891202510},{"date":"2025-10-03","current":14.872209,"twenty":12.744689,"median":14.552446,"eighty":23.767576,"marketCap":22761916339},{"date":"2025-10-10","current":14.331924,"twenty":12.768217,"median":14.566034,"eighty":23.767576,"marketCap":21935010006},{"date":"2025-10-17","current":13.627829,"twenty":12.800753,"median":14.566034,"eighty":23.767576,"marketCap":20857392711},{"date":"2025-10-24","current":14.376948,"twenty":12.815401,"median":14.566034,"eighty":23.767576,"marketCap":22003918867},{"date":"2025-10-31","current":13.64509,"twenty":12.835544,"median":14.566034,"eighty":23.767576,"marketCap":21948126913},{"date":"2025-11-07","current":14.295377,"twenty":12.856703,"median":14.566034,"eighty":23.767576,"marketCap":22994114113},{"date":"2025-11-14","current":15.0241,"twenty":12.876589,"median":14.580992,"eighty":23.767576,"marketCap":24166265266},{"date":"2025-11-21","current":15.338755,"twenty":12.892701,"median":14.616037,"eighty":23.767576,"marketCap":24672388104},{"date":"2025-11-28","current":16.606041,"twenty":12.898117,"median":14.627581,"eighty":23.767576,"marketCap":26710816174},{"date":"2025-12-05","current":16.597376,"twenty":12.924896,"median":14.649467,"eighty":23.767576,"marketCap":26696879458},{"date":"2025-12-12","current":15.732758,"twenty":12.948031,"median":14.673093,"eighty":23.767576,"marketCap":25306141920},{"date":"2025-12-17","current":15.641554,"twenty":12.975038,"median":14.676206,"eighty":23.767576,"marketCap":25159439648}],"updateTime":1766079686690},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIIB\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2588114000","title":"Biogen Shares New Leqembi Data on Slower Alzheimer's Progression, Injection Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2588114000","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588114000?lang=en_us&edition=fundamental","pubTime":"2025-12-04 17:46","pubTimestamp":1764841615,"startTime":"0","endTime":"0","summary":"Biogen  said Wednesday that new trial analyses of Leqembi indicated that starting and continuing treatment early in Alzheimer's may keep patients at milder stages for longer and supported a subcutaneous dosing option for initiation.Looking over a 10-year period using data from the Clarity AD extension and other antibody studies, the company estimated that people on long-term Leqembi stayed in earlier disease stages several years longer than a matched group without treatment.For patients who began therapy with lower brain amyloid levels, the projections suggested the shift from early symptoms to moderate Alzheimer's could be pushed back by up to 8.3 years, compared with modeled progression without the drug, the company said.The company also reported fewer systemic infusion reactions in patients switched to the injection regimen, low levels of anti-drug antibodies.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","LU0889565916.HKD","IE00B19Z9Z06.USD","BK4533","BK4139","BK4585","IE00B19Z9P08.USD","LU0234570918.USD","LU0109394709.USD","LU0320765992.SGD","BK4532","IE00B894F039.SGD","BIIB"],"gpt_icon":0},{"id":"2588004690","title":"Should New LEQEMBI Data and Subcutaneous Option Shift the Risk Profile for Biogen (BIIB) Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2588004690","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588004690?lang=en_us&edition=fundamental","pubTime":"2025-12-04 15:18","pubTimestamp":1764832726,"startTime":"0","endTime":"0","summary":"In late November and early December 2025, Eisai and Biogen reported new LEQEMBI (lecanemab) data at the CTAD conference, highlighting long-term “time savings” in Alzheimer’s progression and bioequivalent efficacy and safety for a newly approved subcutaneous maintenance formulation versus the existing intravenous regimen, alongside fresh biomarker evidence from cerebrospinal fluid studies.\nThese findings suggest that earlier and continuous LEQEMBI treatment could meaningfully extend the time...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-biib/biogen/news/should-new-leqembi-data-and-subcutaneous-option-shift-the-ri","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-biib/biogen/news/should-new-leqembi-data-and-subcutaneous-option-shift-the-ri","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B19Z9Z06.USD","BK4585","BK4532","BIIB","IE00B894F039.SGD","BK4139","ISBC","LU0109394709.USD","LU0889565916.HKD","LU0234570918.USD","LU0320765992.SGD","BK4211","BK4588","BK4533","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2588075230","title":"Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2588075230","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588075230?lang=en_us&edition=fundamental","pubTime":"2025-12-04 09:05","pubTimestamp":1764810300,"startTime":"0","endTime":"0","summary":"Details of failed studies cast pall on Novo Nordisk's GLP-1 as Alzheimer's treatment Trials see no cognitive benefit from semaglutide for Alzheimer's Modest improvement seen in about a quarter of measured biomarkersSafety and tolerability consistent with previous trialsBy Deena Beasley and Julie Steenhuysen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL1N3X917F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","LU0109394709.USD","BK4533","BK4532","LU0234570918.USD","BK4139","BK4585","LU0889565916.HKD","BIIB","BK4588","IE00B19Z9P08.USD","LU0320765992.SGD","IE00B894F039.SGD"],"gpt_icon":1},{"id":"2588802069","title":"Eisai Presents New Data on the Continued and Expanding Benefit of Leqembi® (Lecanemab-Irmb) Maintenance Treatment in Early Alzheimer's Disease at the Clinical Trials on Alzheimer's Disease (Ctad) Conference 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588802069","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588802069?lang=en_us&edition=fundamental","pubTime":"2025-12-04 07:10","pubTimestamp":1764803402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nTUA37YQ0R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B894F039.SGD","LU0109394709.USD","LU0320765992.SGD","BK4139","LU0234570918.USD","BIIB","BK4585","BK4588","BK4533","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU0889565916.HKD","BK4532"],"gpt_icon":0},{"id":"2588706497","title":"Biogen and Eisai Present New LEQEMBI Biomarker Data at Clinical Trials on Alzheimer's Disease 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706497","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588706497?lang=en_us&edition=fundamental","pubTime":"2025-12-03 06:58","pubTimestamp":1764716292,"startTime":"0","endTime":"0","summary":"Biogen  and Eisai announced Tuesday that new data presented at the Clinical Trials on Alzheimer's Disease 2025 conference showed LEQEMBI produced measurable changes in levels of A-beta protofibrils in cerebrospinal fluid in a Phase 3 sub-study, Eisai said Tuesday.In the 410-patient cohort, Eisai said total protofibril levels increased more in the LEQEMBI group than in placebo at 12 and 18 months, with a statistically significant difference at 12 months. Eisai and Biogen said the results confirm that LEQEMBI binding to protofibrils can be measured in cerebrospinal fluid.Eisai said correlations seen in the placebo group between protofibril changes and several neurodegeneration and tau biomarkers were not observed with LEQEMBI treatment.Eisai leads development and regulatory submissions for LEQEMBI globally, and the companies co-commercialize the drug.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z9P08.USD","IE00B894F039.SGD","IE00B19Z9Z06.USD","LU0320765992.SGD","BK4588","BIIB","LU0889565916.HKD","BK4533","LU0109394709.USD","LU0234570918.USD","BK4532","BK4585","BK4139"],"gpt_icon":0},{"id":"2588006131","title":"Biogen Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2588006131","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588006131?lang=en_us&edition=fundamental","pubTime":"2025-12-03 06:04","pubTimestamp":1764713040,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  advanced 1.35% to $180.18 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 0.25% to 6,829.37 and the Dow Jones Industrial Average  rising 0.39% to 47,474.46.Biogen Inc. closed 2.69% short of its 52-week high of $185.17, which the company reached on November 24th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 0.04% to $205.42, Pfizer Inc.  fell 0.47% to $25.15, and AbbVie Inc.  fell 0.33% to $224.37.Trading volume  eclipsed its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 2, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB"],"gpt_icon":0},{"id":"2588069115","title":"Biogen Announces New Data Confirming LEQEMBI Reduces Neurotoxic Amyloid Protofibrils in Alzheimer's Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2588069115","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588069115?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:40","pubTimestamp":1764711657,"startTime":"0","endTime":"0","summary":"Biogen Inc. and Eisai Co., Ltd. have announced new data confirming the pharmacological effect of LEQEMBI , an anti-Aβ protofibril antibody, on neurotoxic Aβ protofibrils in cerebrospinal fluid . The results were presented at the 18th Clinical Trials on Alzheimer's Disease  Conference in 2025. The study showed that lecanemab treatment led to a significant increase in total CSF protofibril concentration at 12 months compared to placebo, suggesting target engagement and mobilization of protofibrils from the brain parenchyma into the CSF. This data supports the pharmacodynamic effect of lecanemab in patients with Alzheimer's disease.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDLN78rq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9P08.USD","BK4139","IE00B894F039.SGD","LU0234570918.USD","BK4588","LU0889565916.HKD","BK4532","BK4585","BIIB","LU0109394709.USD","BK4533","LU0320765992.SGD","IE00B19Z9Z06.USD"],"gpt_icon":0},{"id":"2588069961","title":"New Data Presented at the Clinical Trials on Alzheimer's Disease (Ctad) Conference 2025 Confirms Pharmacological Effect of Leqembi® (Lecanemab-Irmb) on Neurotoxic aΒ Protofibrils in Csf","url":"https://stock-news.laohu8.com/highlight/detail?id=2588069961","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588069961?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:40","pubTimestamp":1764711600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA2HQNHZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0320765992.SGD","IE00B19Z9Z06.USD","BK4588","LU0234570918.USD","BK4533","IE00B894F039.SGD","LU0109394709.USD","BK4532","BIIB","BK4585","IE00B19Z9P08.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2588143705","title":"Biogen Inc. Stock Underperforms Monday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2588143705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588143705?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:00","pubTimestamp":1764626400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Biogen Inc.  shed 2.37% to $177.78 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.53% to 6,812.63 and Dow Jones Industrial Average  falling 0.90% to 47,289.33.Biogen Inc. closed 3.99% short of its 52-week high of $185.17, which the company achieved on November 24th.The stock underperformed when compared to some of its competitors Monday, as Johnson & Johnson  fell 0.76% to $205.34, Pfizer Inc.  fell 1.83% to $25.27, and AbbVie Inc.  fell 1.14% to $225.11.Trading volume  eclipsed its 50-day average volume of 1.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB"],"gpt_icon":0},{"id":"1187950486","title":"Vaccine Stocks Falls as FDA Vows to Impose New Vaccine Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=1187950486","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187950486?lang=en_us&edition=fundamental","pubTime":"2025-12-01 23:25","pubTimestamp":1764602721,"startTime":"0","endTime":"0","summary":"Moderna Inc. fell Monday after the Food and Drug Administration said in a memo late last week it would place new restrictions on which vaccines hit the market.Vinay Prasad, a top FDA official, blamed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"de4e5ce05b2acd5962228944615f4d01","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","BNTX","AZN","MRNA","MRK","VIR","AMGN","NVAX","HIMS","REGN","BIIB"],"gpt_icon":0},{"id":"2588833727","title":"Stoke Therapeutics Reports Zorevunersen Shows Disease-Modifying Effects in Dravet Syndrome Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2588833727","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588833727?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:30","pubTimestamp":1764592247,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on December 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDLbx0vk9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","BK4532","STOK","BK4533","IE00B894F039.SGD","BIIB","BK4588","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0234570918.USD","LU0109394709.USD","BK4585","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2588672766","title":"Biogen and Stoke Therapeutics Announce Presentations at the 2025 American Epilepsy Society Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2588672766","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588672766?lang=en_us&edition=fundamental","pubTime":"2025-12-01 20:30","pubTimestamp":1764592200,"startTime":"0","endTime":"0","summary":"New analyses from the ongoing open label extension (OLE) studies and findings from electroencephalogram (EEG) assessments in patients with Dravet syndrome treated with zorevunersen support the potenti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/01/3196905/0/en/Biogen-and-Stoke-Therapeutics-Announce-Presentations-at-the-2025-American-Epilepsy-Society-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIIB","LENZ","AFG"],"gpt_icon":0},{"id":"2587958277","title":"A Look at Biogen's Valuation as It Expands Immunology Pipeline With Dayra Therapeutics Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2587958277","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587958277?lang=en_us&edition=fundamental","pubTime":"2025-11-30 12:24","pubTimestamp":1764476682,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) just announced a new research partnership with Dayra Therapeutics focused on developing oral macrocyclic peptides for immunological conditions. This forward-looking strategy could reshape the company’s immunology portfolio and draw attention from investors.\nSee our latest analysis for Biogen.\nBiogen’s recent step into oral macrocyclic peptide development aligns with a noticeable upswing in its share price. The stock is up 21.7% over the past month alone, adding to a 21.4%...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-biib/biogen/news/a-look-at-biogens-valuation-as-it-expands-immunology-pipelin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-biib/biogen/news/a-look-at-biogens-valuation-as-it-expands-immunology-pipelin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","LU0889565916.HKD","IE00B19Z9Z06.USD","BK4533","BK4139","BK4585","IE00B19Z9P08.USD","LU0234570918.USD","LU0109394709.USD","LU0320765992.SGD","BK4007","LENZ","BK4539","BK4532","IE00B894F039.SGD","BIIB"],"gpt_icon":0},{"id":"2586181738","title":"Sector Update: Health Care Stocks Mixed Premarket Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2586181738","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586181738?lang=en_us&edition=fundamental","pubTime":"2025-11-28 22:20","pubTimestamp":1764339612,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Friday, with the Health Care Select Sector SPDR Fund (XLV) slightly lower and the iShares Biotechnology ETF (IBB) up 0.3%.Biogen (BIIB) and Eisai said a new dru","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0234570918.USD","XBI","BK4139","IE00B19Z9Z06.USD","PTIX","IE00B894F039.SGD","BIIB","VNDA","IE00B19Z9P08.USD","BK4532","BK4581","BK4533","IBB","BK4588","LU0109394709.USD","XLV","LU0320765992.SGD","LU0889565916.HKD","LABU","BK4585"],"gpt_icon":0},{"id":"2586782142","title":"U.S. RESEARCH ROUNDUP-Biogen, Deere & Co, Sherwin-Williams","url":"https://stock-news.laohu8.com/highlight/detail?id=2586782142","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586782142?lang=en_us&edition=fundamental","pubTime":"2025-11-28 20:58","pubTimestamp":1764334702,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Biogen, Deere & Co, Sherwin-WilliamsNov 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biogen,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nL4N3X40QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1201861249.SGD","LU1988902786.USD","LU1064131342.USD","LU1861214812.USD","LU1917777945.USD","LU0289739343.SGD","BK4090","LU2491050154.USD","LU2357305700.SGD","IE00B894F039.SGD","LU1720051108.HKD","AKR","BK4533","DE","LU1093756168.USD","BK4532","BIIB","LU0323240290.USD","LU0980610538.SGD","BK4152","IE00BZ1G4Q59.USD","SG9999002521.SGD","SG9999011175.SGD","LU1093756325.SGD","LU2491050071.SGD","LU1548497426.USD","LU0648001328.SGD","IE00BD6J9T35.USD","LU0061475181.USD","LU1989763427.SGD","LU2023250843.SGD","LU1861219969.SGD","SGXZ23171101.USD","BK4109","BK4588","ARQT","LU2023250504.SGD","BK4080","BK4597","LU1718418525.SGD","CBT","LU0477156953.USD","LU1989763690.USD","LU1720051017.SGD","LU2264538146.SGD","GB00BDT5M118.USD","ECVT","SHW"],"gpt_icon":0},{"id":"2586855057","title":"Jefferies Adjusts Price Target on Biogen to $210 From $190, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2586855057","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586855057?lang=en_us&edition=fundamental","pubTime":"2025-11-28 18:22","pubTimestamp":1764325352,"startTime":"0","endTime":"0","summary":"Biogen (BIIB) has an average rating of overweight and mean price target of $180.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major bank","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIIB"],"gpt_icon":0},{"id":"2586276987","title":"Eisai and Biogen Submit Subcutaneous LEQEMBI for Regulatory Review in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2586276987","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586276987?lang=en_us&edition=fundamental","pubTime":"2025-11-28 08:35","pubTimestamp":1764290134,"startTime":"0","endTime":"0","summary":"Eisai Co., Ltd. has submitted a new drug application to Japan's Pharmaceuticals and Medical Devices Agency  for a subcutaneous formulation of LEQEMBI , a treatment for early Alzheimer's disease. The application is based on clinical data showing similar effectiveness and safety between the new subcutaneous autoinjector and the existing intravenous formulation. Biogen Inc. is co-developing and co-commercializing LEQEMBI with Eisai, but the regulatory submission was made by Eisai. Regulatory review of this new formulation is now underway in Japan.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biogen Inc. published the original content used to generate this news brief on November 27, 2025, and is solely responsible for the information con","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL9vtgHD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z9Z06.USD","BK4585","BK4532","BIIB","IE00B894F039.SGD","BK4139","LU0889565916.HKD","LU0109394709.USD","LU0234570918.USD","LU0320765992.SGD","BK4588","BK4533","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2586470017","title":"FDA Decision Opens Bigger Market for Novartis's Blockbuster Gene Therapy -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2586470017","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586470017?lang=en_us&edition=fundamental","pubTime":"2025-11-26 01:28","pubTimestamp":1764091680,"startTime":"0","endTime":"0","summary":"The Food and Drug Administration has approved a version of the Novartis gene therapy Zolgensma, used to treat infants with spinal muscular atrophy, that will allow older patients to take the treatment.The go-ahead, which came late Monday, will allow Novartis to keep building on what has been a rare commercial success in the troubled field of gene therapy. At an investor event last week, Novartis CEO Vas Narasimhan said that the new version had \"the opportunity to be a multibillion-dollar medicine.\". Zolgensma sales were $1.2 billion last year. The consensus call among analysts tracked by FactSet is that sales of the new version of the drug will hit $510 million in 2027.Zolgensma, which the FDA approved in 2019, is only available for children under the age of 2. The new version, which Novartis will sell under the brand name Itvisma, is approved for spinal muscular atrophy patients aged 2 and older.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","BK4585","NVS","IE0009355771.USD","LU0109394709.USD","BK4588","BK4139","LU0211331839.USD","LU0320765489.SGD","IE00B894F039.SGD","IE00B19Z9P08.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4532","BIIB","IE00B19Z9Z06.USD","BK4007","BK4533","IE0002141913.USD","BK4578","LU0320765992.SGD","LU0208291251.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0889565916.HKD","LU0070302665.USD","LU0234570918.USD"],"gpt_icon":0},{"id":"2586547785","title":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-11-25","url":"https://stock-news.laohu8.com/highlight/detail?id=2586547785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586547785?lang=en_us&edition=fundamental","pubTime":"2025-11-26 00:01","pubTimestamp":1764086465,"startTime":"0","endTime":"0","summary":"BUZZ - Nasdaq top and bottom performing stocks at about 11:01 a.m. EST on 2025-11-25Nasdaq 100 .NDXTop PerformersPercent ChangeGE Healthcare Technologies Inc GEHC.OQ+4.3%Lululemon Athletica Inc LULU.OQ+3.4%Biogen Inc BIIB.OQ+3.2%Analog Devices Inc ADI.OQ+3.1%Airbnb Inc ABNB.OQ+2.9%Bottom PerformersPercent ChangeAdvanced Micro Devices Inc AMD.OQ-7.5%NVIDIA Corp NVDA.OQ-5.5%Arm Holdings PLC ARM.OQ-5.1%Strategy Inc MSTR.OQ-3.6%Applovin Corp APP.OQ-3.4%The Nasdaq 100 .NDX lost 130.61 points, or 0.52%, to 24,743.24 and recorded 7 new highs and no new lows. 70 stocks rose and 31 fell as advancing issues outnumbered decliners by a about a 2.3-to-1 ratio.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nL8N3X11DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1791710400.SGD","IE00BN29S564.USD","LU0957791311.USD","LU0823411888.USD","LU1670711123.USD","2NVD.UK","SNVD.UK","NVDY","LU0323591593.USD","NVD3.UK","ABNB","LU0985320562.USD","NVDU","SG9999000418.SGD","LU0211327993.USD","LU0211328371.USD","LU0107464264.USD","NVD","NVDA","GEHC","LU1791710582.SGD","LU0965509101.SGD","AMD","LU1989764748.USD","ARM","STRK","APP","NVDS","MSTR","LU0130518102.USD","LU2092627202.USD","LU2237443549.SGD","BK4554","ADI","LU1548497426.USD","LU1642822529.SGD","NVD2.UK","NVDS.UK","LULU","NVIW.SI","IE00B1XK9C88.USD","3NVD.UK","BIIB","LU0157215616.USD","IE00B1BXHZ80.USD","LU0345770308.USD","NVDD"],"gpt_icon":1},{"id":"2586759864","title":"Biogen, Eisai Submit Supplemental Biologics License Application to FDA for Weekly Lecanemab Injections","url":"https://stock-news.laohu8.com/highlight/detail?id=2586759864","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586759864?lang=en_us&edition=fundamental","pubTime":"2025-11-25 21:24","pubTimestamp":1764077042,"startTime":"0","endTime":"0","summary":"Biogen  and Eisai said Tuesday Eisai has completed the rolling submission of a supplemental Biologics License Application to the US Food and Drug Administration seeking approval for a weekly subcutaneous starting dose of lecanemab-irmb.The companies said the treatment is approved for Alzheimer's patients in the mild cognitive impairment or mild dementia stages. Esai serves as the lead for lecanemab development, while Esai and Biogen co-promote and co-commercialize the product.Once the FDA accepts the application, it will set a review date, they added.The drugmakers said the filing includes data from studies evaluating various doses, as well as sub-studies within the phase 3 open-label extension study.If approved, the drug's 500 mg regimen - given as two 250 mg autoinjector shots - would allow patients to start treatment through once-weekly injections at home instead of bi-weekly IV infusions,  the company said.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B19Z9Z06.USD","BK4585","BK4588","BK4532","LU0234570918.USD","BK4139","BK4533","LU0889565916.HKD","IE00B894F039.SGD","LU0320765992.SGD","BIIB","IE00B19Z9P08.USD","LU0109394709.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":198,"code":"91000000","status":"200"}]}}